In this issue:
Validation of “probable COPD” as proposed by the Lancet Commission
Comparison of mild-to-moderate COPD with vs without emphysema
Identifying abnormal exertional breathlessness in COPD
Peak inspiratory flow and inhaler prescription strategies
Education improves inhalation skills regardless of inhaler type
Dupilumab for COPD with type 2 inflammation
Impact of home-based PR for outpatient-managed COPD exacerbations
Utility of smartphone app-based PR
MHR is a promising predictor of coronary artery disease in COPD patients
Association between NHHR and mortality in patients with COPD
Please login below to download this issue (PDF)